Cibus, Inc. engages in the research and development of plant traits to seed companies for royalties. The company is headquartered in San Diego, California. The company went IPO on 2017-07-20. Its business is the development of plant traits for some of the agricultural food crops that help address specific productivity, profitability, sustainability, or yield challenges in farming. Its core technology propriety gene editing platform is called the Rapid Trait Development System (RTDS). The company is the underlying technology in the Company's Trait Machine process, an end-to-end semi-automated high-throughput gene editing system that directly edits seed companies' elite germplasm. The company has a pipeline of five productivity traits. The company has developed the productivity trait Pod Shatter Reduction (PSR) in Canola and Winter Oilseed Rape (WOSR) strengthens the sheath around the canola seeds. Its advanced productivity traits, Sclerotinia resistance and HT2 in Canola and WOSR, continue to progress and offer white mold disease resistance and broadleaf weed herbicide tolerance.
CBUS 'in mevcut fiyatı $2.79 'dir, son işlem günde 0.72% arttırılmış etti.
Cibus Inc için ana iş temaları veya sektörler nelerdir?
Cibus Inc Biotechnology endüstrisine ait ve sektör Health Care 'dir
Cibus Inc 'in piyasa değerlemesi nedir?
Cibus Inc 'in mevcut piyasa değerlemesi $189.4M 'dir
Cibus Inc al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 5 analist Cibus Inc için analist derecelendirmeleri gerçekleştirdi, bunlar 2 güçlü al, 6 al, 2 tut, 0 sat ve 2 güçlü sat içermektedir